A practical method of breath-by-breath monitoring of metabolic gas exchange has previously been developed by GE Healthcare and can now be easily incorporated into existing anaesthetic and critical care monitoring (M-COVX). Previous research using this device has shown good accuracy and precision between the M-COVX measurements and a traditional measurement of gas uptake at the mouth and also against the reverse Fick method during cardiac surgery and critical care, but its accuracy in the paediatric situation and across a range of ventilatory settings awaits validation. We tested the M-COVX metabolic monitor in the laboratory comparing its measurement to a traditional Haldane transformation across a wide range of oxygen consumption values, from 50 ml/minute to just under 300 ml/minute, typical of those expected in anaesthetised adults and children. The M-COVX device showed acceptable accuracy with an overall mean bias of -3.3% (range -15.1 to +4.2%, P=0.21). Excellent linearity was found, by y=0.96x + 0.5 ml/minute, r=0.99. The device showed acceptable robustness to ventilatory changes examined, including changes in respiratory rate, I:E ratio, FiO 2 up to 75% and simulated spontaneous breathing. However, any induced leak from around the simulated endotracheal tube caused a significant error in paediatric scenarios.
Measurement of uptake or elimination of a gas species by the lungs is usually achieved by determining the difference between flow of the gas into and out of a closed or semi-closed breathing system. Previous devices for measurement of oxygen consumption ( ) in the clinical setting, such as the Datex-Ohmeda Deltatrac (Datex-Ohmeda, Helsinki, Finland) relate total flow rate out of the system to measured flow into the system by using the difference in measured nitrogen (N 2 ) concentration in each (the Haldane transformation). They have relied for accuracy on collection and measurement of N 2 in mixed exhaust gas. This requires some modification of a standard breathing circuit, and the added volume of a mixing box or tubing delays the response of the measurement to changes in gas exchange.
This has become more practical with the introduction of a new device, the M-COVX (GE Healthcare, Helsinki, Finland), which is easily integrated into existing breathing systems. The M-COVX system permits breath-by-breath measurement of from integration of continuous sidestream gas concentration measurements and flow measurements made at the mouth by a differential pressure flow sensor (D-lite+). A low volume sensor designed for paediatric use (Pedilite) is also available. Later versions, such as the M-CAiOVX, include anaesthetic gas concentration measurement as well to widen the functionality of the device for monitoring during anaesthesia. Like the Deltatrac, the device uses an algorithm which relates inspired to expired flow rates from N 2 concentration measurement. A minimum inspired N 2 concentration of 15% is required for accuracy according to the manufacturer's specifications.
Measurement at the mouthpiece like this potentially allows rapid detection of real changes in alveolarcapillary gas exchange.
The overall accuracy of the M-COVX in measurement has been confirmed clinically in adults in intensive care 1 and during cardiac surgery against the reverse Fick method, using mixed venous blood sampling 2 . However, comparison of agreement with the Deltatrac in the intensive care setting has yielded mixed results 1, 3, 4 . Comparisons of this nature are often clouded by the limitations in precision and reproducibility of measurement by the reference method. Furthermore, validation in the paediatric setting is required, given the different range of ventilatory settings and gas flows used in children. Such data have not been published, and this may arise from the practical and ethical difficulties of conducting a study such as this in anaesthetised children. These difficulties have probably contributed to the paucity of data examining the effects of anaesthesia on gas exchange and metabolic rate in children. These limitations can be overcome by using a lung gas exchange simulator, which allows testing of the device across a wide range of settings and simulated gas exchange values, while providing a reliable 'gold standard' reference method 5 . We tested an M-CAiOVX device (referred to hereafter as the M-COVX) in measurement of simulated over a range of scenarios representing ventilatory settings and gas exchange values seen in age groups ranging from infants to adults.
METHODS

Simulator design
The central component of the lung gas exchange simulator was a hinged bellows device ("artificial lung", Dual TTl type 1600, Michigan instruments inc, uSA). using previously described methodology 6 , uptake of oxygen (O 2 ) and the production of carbon dioxide (CO 2 ) were simulated by infusing metered flows of CO 2 and N 2 into one bellows of the artificial lung. CO 2 infusion directly simulates CO 2 production, while infusion of other gases which are present in the inspired gas mixture alters their exhaust gas concentrations by relative dilution or enrichment, thereby simulating "apparent" gas exchange. infusion of pure N 2 into the ventilated lung simulates "apparent" uptake of alveolar O 2 by dilution. To achieve realistic lung gas exchange, infusion of diluting N 2 is combined with controlled extraction of well mixed gas from the lung, so that total exhaust gas flow matches that expected if true gas uptake by pulmonary blood was occurring. Extraction was done by application of suction via a variable suction regulator attached to mains pressure suction from a wall outlet. Full mixing of alveolar gases was assisted by vigorous agitation of the alveolar gas mixture by an electric cooling fan of the type used in electronic equipment. The compliance of the artificial lung and inspiratory pressures could be varied by changing the position of steel coils attached to the lid of the bellows and the base of the unit.
Calculation of the required gas infusion rates and suction flow rate for any given gas exchange scenario was done on the principle of mass balance within the system, as previously described 6 . Flows of gas into the lung were controlled by feeding each gas species through a length of hollow fine bore (0.5 to 0.7 mm internal diameter) stainless steel tubing connected to a variable pressure regulator. Gas extraction flow was controlled by drawing "alveolar" gas through a length of plastic gas sampling tubing which was connected at one end to the test lung and at the other to medical suction via a variable suction regulator. All gas flow rates into and out of the system were measured volumetrically using either a 50 ml or 1 litre dry gas syringe, and adjusted to meet the previously calculated values.
The breathing system was attached to an anaesthetic machine (TM41 Anaesthetic Major Apparatus, CiG, Australia) and to the artificial lung via a length of serial deadspace tubing whose length was adjusted to reflect a physiologically realistic anatomical deadspace volume for each scenario, and which incorporated an appropriate length of endotracheal tubing and a paediatric or adult breathing filter depending on the scenario being simulated. Ventilation was provided by an Ohmeda 7800 anaesthesia ventilator (Datex-Ohmeda, Helsinki, Finland) attached to the exhaust limb of the breathing system, to provide intermittent positive pressure ventilation (iPPV). Where spontaneous breathing was simulated, this was achieved as previously described 7 by locking the two bellows of the dual TTl artificial lung together and providing positive pressure ventilation to the other artificial lung bellows via a separate ventilator circuit. This passively moved the artificial lung bellows, to which the simulator breathing system was attached, along with a 500 ml black rubber bag at the end.
The precise value achieved for simulated oxygen uptake in each scenario was measured using a measurement system which consisted of sampling lines from fresh gas and mixed exhaust gas sampling points connected via a three way tap to a multi-gas analyser (Capnomac Ultima, Datex-Ohmeda, Finland), data module and personal computer with analogue input boards. Fresh gas flow was measured using the 1 litre dry gas syringe, and gas concentrations in fresh gas and mixed exhaust gas were sampled sequentially. Simulated ( sim) was then measured using a standard indirect calorimetry technique, according to the principle of mass balance of O 2 and N 2 between fresh gas and mixed exhaust gas streams within the breathing circuit:
where is total fresh gas flow rate, is total mixed exhaust gas flow rate and and are fractional concentrations of O 2 in fresh gas and mixed exhaust gas respectively. According to the Haldane transformation 8 :
then The mixing of exhaust gas was achieved by sampling exhaust gas downstream of the ventilator bellows and by interposing an additional length of exhaust tubing between the ventilator and the exhaust limb of the circuit. The breathing system, gas exchange simulator and apparatus for measurement of gas exchange are shown schematically in iPPV configuration in Figure 1 . For each scenario, sim from equation (3) was considered the target value for comparison with the M-COVX measurement.
M-COVX validation protocol
The flow transducer of the M-COVX was connected into the breathing system at the appropriate point just proximal to the filter. The M-COVX was calibrated according to the manufacturer's instructions using a cylinder of proprietary calibration gas (QuiCk CAl, Ge Healthcare, Helsinki, Finland), and the monitor set to display and record measurements at actual temperature and pressure dry.
in the first part of the study, the linearity of the device in measurement of was tested across eight scenarios simulating gas exchange with sim between 50 ml/min and 300 ml/min, with a fresh gas O 2 concentration (FfO 2 ) of 50%. Four of these scenarios with lower sim were designed as
(3) 'paediatric' scenarios, with the Pedi-lite connector in place and a T-piece breathing system, and fresh gas flow rate, ventilatory settings and deadspace volumes chosen to reflect typical values for a child with a of that magnitude. The other four 'adult' scenarios were simulated with the D-lite connector in place and a circle absorber breathing system, with typical settings and deadspace for an adult patient. These are summarised in Table 1 . For each scenario, following an equilibration period of approximately three to five minutes, data was collected for approximately 1.5 minutes and logged to hard disk. The M-COVX recorded during this period at five second intervals, which provided 20 consecutive measurements for each scenario, which were averaged to obtain M-COVX. From this data a mean difference and standard deviation (SD) of the difference were calculated. For these eight scenarios, statistical significance of differences was determined using the t-test and correlation against target values was measured using the correlation coefficient.
in the second part of the study, a variety of different ventilatory changes were applied in order to observe their influence on the accuracy of the measurement. The accuracy of the device was re-assessed across three 'paediatric' scenarios with spontaneous ventilation being simulated and with the respiratory rate being increased (High RR) or decreased (low RR) by 10 breaths/min. in three scenarios, the FfO 2 was increased to 75% to examine the effect of a reduction in N 2 concentration on the accuracy of the device.
in a further five scenarios the effect of varying the i:e ratio from 1:1 to 1:3 was examined, as was that of reducing the lung compliance so as to increase peak inspiratory pressure from 20 cmH 2 O to 35 cmH 2 O. in three paediatric scenarios, to test the effect of using an uncuffed endotracheal tube, a controlled airway leak was introduced at the level of the 'mouth' of the simulator, sufficient to produce an audible leak in a similar fashion to common clinical practice.
Finally, we measured the response time of the device to a step change in sim produced by suddenly altering gas infusion and extraction flow rates in a pre-determined manner for several minutes and then returning them to their original settings. This was done three times. The resting volume of the bellows of the artificial lung was set at 2.0 l during this part of the experiment to simulate a physiologically realistic resting lung volume.
RESULTS
Linearity test
The agreement between the sim and M-COVX for the eight scenarios is shown in Table 1 . Mean difference was -3.3% (-5.6 ml/min, P=0.21), ranging from -15.1 to 4.2% of sim. The relationship between sim and M-COVX was described by y=0.96x + 0.5 ml/min. The correlation coefficient r was 0.99. The relationship is displayed graphically in Figure 2 . Table 2 shows the results from the scenarios where respiratory rate and FfO 2 were altered and spontaneous ventilation was simulated. No physiologically significant change in mean difference from sim was found. However, the standard deviation of M-COVX was noted to increase three-fold at the FfO 2 of 75%, compared with that at 50%. figuRe 2: linearity of measurement of on the lung gas exchange simulator ( sim) by the M-COVX ( M-COVX) across the eight scenarios where was varied between 50 ml/min and 300 ml/min, in comparison with measurements made by the standard indirect calorimetry method using the Haldane transformation applied to mixed exhaust gases. Ninety-five percent response of the measured value is indicated for both increase and decrease in sim.
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DiSCuSSiON
Our results show the M-COVX metabolic rate monitor to have acceptable accuracy over a range of simulated conditions typical of paediatric and adult ventilation and anaesthesia. We found an overall mean bias of -3.3%, with a range of biases between -15.1% and +4.2% from our calculated values. This accuracy is well within acceptable limits for most clinical and many research applications. its ease of use may make routine clinical use of metabolic monitoring more feasible, as well as improving understanding in areas such as paediatric anaesthesia, where such monitoring has to date been difficult and limited.
The potential of metabolic monitoring is yet to be fully defined. in the critical care setting, it has been explored for the prediction of outcome, direction of therapy and resuscitation, to determine nutritional requirements and to stratify the degree of metabolic stress in systemic inflammatory states [9] [10] [11] [12] . indirect calorimetry measures from the difference in oxygen and inert marker gas concentrations between inspired and expired gases. As outlined previously, the Haldane transformation is routinely used in indirect calorimetry techniques, utilising the inert nature of nitrogen in lung gas exchange. This allows the volume of either of the inspired or expired gases to be calculated when the other is measured, which reduces error despite the fact that N 2 concentration is unable to be measured directly by standard clinical monitors and is calculated by subtraction of the measured concentration of the other gases in the mixture. indirect calorimetry has undergone considerable evolution and refinement over the last 30 years, and is considered by many to have surpassed techniques relying on the Fick principle, as the more reliable standard for the measurement of metabolic rate 13, 14 . Nevertheless, widely accepted and validated indirect calorimeters, such as the Deltatrac or the custom-made system employed as the reference method in our study, have significant limitations including expense, bulk, laborious calibration requirements and limitations regarding the types of circuits and ventilators that they can be adapted to. They also suffer more prolonged response times, associated with the need for exhaust gas mixing, that limit their utility in settings such as the operating theatre. in these regards, the M-COVX offers a significant advance. it is light and portable, integrates easily into Datex-Ohmeda monitoring systems, operates independently of the ventilator or circuit set-up, has a brief (15 minute) warm-up and relatively rapid response time to changes in . Breath-to-breath measurement of by the M-COVX is averaged over 60 seconds to achieve data smoothing for display. Our data revealed a response time to a step change in simulated of slightly over one minute. it should be pointed out that this experiment produced a sudden change in simulated alveolarcapillary O 2 uptake, which, as is the case in the real lung, is not immediately reflected in measured at the level of the mouth due to the finite rate of wash-in or wash-out of alveolar gas concentrations consequent to the change 15 . While some of the delay we observed may arise from averaging of breath-tobreath measurements by the device, a considerable part of it is due to this physiologically realistic delay.
The M-COVX constructs continuous gas concentration curves from sidestream sampling at the patient airway and flow/volume curves from a fixed-resistance pneumotachograph at the same location (D-lite or Pedi-lite). A modification of the Haldane transformation is applied to the measured inspired tidal volume, and this data is then integrated with the gas concentration curves to calculate the consumed O 2 and produced CO 2 for that breath. in common therefore, with earlier generation devices using the Haldane technique, the accuracy of the M-COVX is reduced at high inspired concentrations of oxygen 16, 17 . Our study found a mean bias of -15% at an FfO 2 of 75%, which is near the limit of accuracy predicted by the manufacturer for FiO 2 between 65 to 85%. it will be less useful, therefore, in the critically ill with high inspired oxygen requirements. For inspired oxygen concentrations less than 65%, the manufacturer claims an accuracy of 10 ml or +/-10%, which has been validated in adults, but not in children. Stuart-Andrews et al 2 found an overall bias of +1.8% in 11 adult cardiac patients. The consistency, but not accuracy, of the M-COVX has been assessed in a paediatric intensive care unit, where changes in ventilator mode between pressure regulated volume control, synchronised intermittent mandatory ventilation and BiVeNT produced no significant change in the calculated energy expenditure 18 .
Data from adult patients are more available in the literature and results have been mixed. McLellan et al 1 found no significant bias during their comparison of the M-COVX with the (previously validated) Deltatrac ii monitor in 20 intensive care unit patients, but the limits of agreement between the two monitors were wide (up to ± 64 ml/min). Singer et al 3 also found significant scatter in agreement between these two devices, and a recently published study by Meyer et al 4 found both a significant negative bias (-46 ml/min) and prohibitive degree of scatter in agreement between sequential measurements obtained from the M-COVX and Deltatrac. Furthermore, they found the M-COVX frequently failed to deliver a measurement of oxygen uptake at all, presumably in response to unstable input measurements of gas flow and concentration. However, agreement with the Deltatrac, which does not represent a gold standard, provides only limited information on the true accuracy of the M-COVX. in contrast, studies such as ours, which tested the M-COVX under controlled and stable conditions against a reliable in vitro standard, can be more informative, despite not being able to directly address the performance of the device in the clinical setting.
The M-COVX has some other limitations. The performance of the M-COVX has been shown to be prone to error when used for prolonged periods, particularly with humidified circuits, due to accumulation of water in the pneumotachograph 19 . it is not adaptable to "open" or head-box techniques.
There are better suited monitors for this setting, although it would be clearly attractive to use the same monitor both before and during anaesthesia, for example. Being reliant on a sealed airway circuit and designed specifically for ventilated patients, its utility for awake studies would be dependent on the subject's ability to co-operate in achieving an adequate seal at the mouth/nosepiece. Despite our demonstration of its accuracy at paediatric levels of simulated , our study demonstrated the need for a sealed circuit, with prohibitive inaccuracies noted when an audible leak was introduced around the simulated endotracheal tube. Practically, this means that in the intensive care unit and the operating theatre a cuffed endotracheal tube will be necessary for accuracy, or a well seated laryngeal mask airway, with confirmation on spirometry of no leak at the pharynx. This may represent a departure from normal practice in paediatrics. The manufacturer's stated range of function for is 50 to 1000 ml/min. They also recommend a respiratory rate less than 35. Term neonates fall outside these ranges, so one cannot expect the unit to be useful in neonatal settings. Only limited work has been conducted examining the metabolic rate of children under anaesthesia and during surgery, particularly outside the context of cardiac surgery [20] [21] [22] [23] . Consequently, data in this area of basic science is scant. This is of interest considering the fundamental importance of temperature homeostasis during paediatric surgery.
Despite the previously outlined limitations, we considered the potential utility of this monitor in the paediatric operating theatre and intensive care unit to warrant the further validation which we undertook. Our results suggest that during stable ventilation and gas exchange, the M-COVX should be accurate for use in both paediatric and adult anaesthesia and critical care.
